Napigen

Wilmington, United States

NAPIGEN is a biotechnology company that addresses novel genome engineering of various organisms such as plants, microbes, and animals.

Mar 2024

Grant

Top Investors

RA Capital ManagementSVG VenturesBreakout LabsU.S. Department of AgricultureGrantham Foundation

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Napigen's investors?

Napigen's investors include RA Capital Management, SVG Ventures, Breakout Labs, U.S. Department of Agriculture, Grantham Foundation.

Where is Napigen headquartered?

Napigen is headquartered in Wilmington, United States.

What does Napigen do?

NAPIGEN is a biotechnology company that addresses novel genome engineering of various organisms such as plants, microbes, and animals.

What stage is Napigen at?

Napigen is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 11, 2024.

MLA

"Napigen — Funding & Investors." VCBacked, March 11, 2024, https://www.vcbacked.co/company/napigen. Accessed July 1, 2026.

APA

VCBacked. (2024). Napigen — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/napigen

Wikipedia (cite web)

{{cite web |title=Napigen — Funding & Investors |url=https://www.vcbacked.co/company/napigen |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 11, 2024.